Annotation Detail
Information
- Associated Genes
- FASN
- Associated Variants
-
ACTA2 c.-24+1440C>T
(
ENST00000458159.6,
ENST00000713602.1,
ENST00000415557.2 )
FASN SNV ( ENST00000415557.2, ENST00000458159.6, ENST00000713602.1 )
ACTA2 c.-24+733T>C ( ENST00000713602.1, ENST00000458159.6, ENST00000415557.2 )
NC_000001.11:g.172658358C>T
FASLG c.395-124A>G ( ENST00000340030.4, ENST00000367721.3 )
ACTA2 c.-24+1440C>T ( ENST00000415557.2, ENST00000458159.6, ENST00000713602.1, ENST00000690268.1 )
FASN SNV ( ENST00000415557.2, ENST00000458159.6, ENST00000713602.1, ENST00000690268.1 )
ACTA2 c.-24+733T>C ( ENST00000415557.2, ENST00000458159.6, ENST00000713602.1, ENST00000690268.1 )
NC_000001.11:g.172658358C>T
FASLG c.395-124A>G ( ENST00000340030.4, ENST00000367721.3 ) - Associated Disease
- Squamous cell carcinoma of oropharynx
- Source Database
- DisGeNET
- Description
- Thus, we determined the associations between four FAS and FASLG promoter variants (FAS1377G>A, rs2234767; 670A>G, rs1800682; FASLG844T>C, rs763110 and 124A>G, rs5030772) and the risk of recurrence of squamous cell carcinoma of the oropharynx (SCCOP).
- Pubmed
- 25976983
- Original source reporting the Gene Disease association
- BeFree
- DisGENET score for the Gene Disease association
- 0.000271441872080303
- Year of publication
- 2015
Drugs